Literature DB >> 33232791

Symptoms of anxiety, depression, and borderline personality in alcohol use disorder with and without comorbid substance use disorder.

Lindy K Howe1, Lindsey R Fisher1, Emily A Atkinson2, Peter R Finn3.   

Abstract

OBJECTIVE: Alcohol use disorder (AUD) is highly comorbid with other substance use disorders (SUDs) as well as other psychiatric disorders, such as anxiety, depression, and Borderline Personality Disorder (BPD). However, studies of persons with AUD rarely account for its comorbidity with other SUDs. Some research suggests that BPD symptoms reflect an important connection between internalizing disorders and SUDs. The current study investigated: 1) the levels of trait anxiety and symptoms of depression and BPD in persons with an AUD as a function of comorbid SUDs (cannabis use disorder - CUD) and other substance use disorder (oSUD), and 2) the influence of BPD on the association between severity of overall lifetime SUD symptoms (AUD + CUD + oSUD) and both trait anxiety and symptoms of depression.
METHOD: Trait anxiety and symptoms of depression and BPD were assessed in 671 young adults (351 men; 320 women; mean age 21 years) separated into four groups: Controls (n = 185), AUD-only (134), AUD + CUD (n = 210), and AUD + oSUD (n = 142).
RESULTS: Trait anxiety and symptoms of depression and BPD were elevated in all AUD groups compared with controls, and in the AUD + oSUD group compared with all other groups as well. Structural models also indicated that BPD symptoms accounted for all of the variance in lifetime SUD symptoms associated with Trait Anxiety, and a significant portion of the variance in lifetime SUD symptoms associated with depression symptoms.
CONCLUSION: Results indicate that when AUD is comorbid with oSUD, it is associated with more severe AUD symptoms and higher levels of trait anxiety and symptoms of both depression and BPD. The results also indicate that BPD symptoms account for the majority of the variance in SUD symptoms associated with both trait anxiety and depression, suggesting that a considerable amount of the internalizing symptomatology in AUD/SUDs is associated with BPD psychopathology.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Borderline Personality Disorder; alcohol; cannabis; depression; mental health outcomes; substance use; trait anxiety

Mesh:

Year:  2020        PMID: 33232791      PMCID: PMC7854477          DOI: 10.1016/j.alcohol.2020.11.002

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  26 in total

1.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Frederick S Stinson; Bridget F Grant; Deborah A Dawson; W June Ruan; Boji Huang; Tulshi Saha
Journal:  Drug Alcohol Depend       Date:  2005-04-18       Impact factor: 4.492

4.  Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey.

Authors:  R C Kessler; R M Crum; L A Warner; C B Nelson; J Schulenberg; J C Anthony
Journal:  Arch Gen Psychiatry       Date:  1997-04

5.  Polysubstance use, mental health and high-risk behaviours: Results from the 2012 Global Drug Survey.

Authors:  Katherine I Morley; Michael T Lynskey; Paul Moran; Rohan Borschmann; Adam R Winstock
Journal:  Drug Alcohol Rev       Date:  2015-04-13

6.  Alcohol use disorders and the course of depressive and anxiety disorders.

Authors:  Lynn Boschloo; Nicole Vogelzangs; Wim van den Brink; Johannes H Smit; Dick J Veltman; Aartjan T F Beekman; Brenda W J H Penninx
Journal:  Br J Psychiatry       Date:  2012-02-09       Impact factor: 9.319

7.  The structure of genetic and environmental risk factors for DSM-IV personality disorders: a multivariate twin study.

Authors:  Kenneth S Kendler; Steven H Aggen; Nikolai Czajkowski; Espen Røysamb; Kristian Tambs; Svenn Torgersen; Michael C Neale; Ted Reichborn-Kjennerud
Journal:  Arch Gen Psychiatry       Date:  2008-12

8.  The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women.

Authors:  Kenneth S Kendler; Carol A Prescott; John Myers; Michael C Neale
Journal:  Arch Gen Psychiatry       Date:  2003-09

9.  Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health.

Authors:  S L Hedden; S S Martins; R J Malcolm; L Floyd; C E Cavanaugh; W W Latimer
Journal:  Drug Alcohol Depend       Date:  2009-09-15       Impact factor: 4.492

10.  Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs.

Authors:  Jason P Connor; Matthew J Gullo; Gary Chan; Ross McD Young; Wayne D Hall; Gerald F X Feeney
Journal:  Front Psychiatry       Date:  2013-08-07       Impact factor: 4.157

View more
  2 in total

1.  Is lower severity alcohol use disorder qualitatively different than more severe manifestations? An evaluation of multivariate symptom clusters.

Authors:  Allen J Bailey; Polly F Ingram; Lindy K Howe; Peter R Finn
Journal:  Addiction       Date:  2022-01-27       Impact factor: 7.256

Review 2.  Fear of COVID-19, stress and depression: A meta-analytic test of the mediating role of anxiety.

Authors:  Özkan Çıkrıkçı; Neslihan Çıkrıkçı; Mark Griffiths
Journal:  Psychol Psychother       Date:  2022-06-07       Impact factor: 3.966

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.